FundedIQ
Artificial Intelligence

Braingaze

Braingaze addresses significant obstacles related to cognitive disorders of the brain by utilizing a patented neuro-biomarker based on small involuntary eye movements. These movements are induced through functional games, and the resulting data is analyzed using algorithms trained through Deep Learning with real patient/control cases. We focus on the early stages of Alzheimer's disease and ADHD, offering tools that are approved as medical devices with a CE Mark. Our product lineup includes detection/diagnostic tools and digital therapy solutions that have demonstrated a reduction in symptoms by more than 50%.

www.braingaze.com Mataró, Spain 1-10 employees
Total raised
$1.6M
Rounds
1
Latest
Mar 2024

Braingaze addresses significant obstacles related to cognitive disorders of the brain by utilizing a patented neuro-biomarker based on small involuntary eye movements. These movements are induced through functional games, and the resulting data is analyzed using algorithms trained through Deep Learning with real patient/control cases. We focus on the early stages of Alzheimer's disease and ADHD, offering tools that are approved as medical devices with a CE Mark. Our product lineup includes detection/diagnostic tools and digital therapy solutions that have demonstrated a reduction in symptoms by more than 50%.

Braingaze has raised $1.6M across 1 round. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Mar 6, 2024
$1.6M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Braingaze is featured in

Similar companies

Anyformat

Anyformat is a solution to extract structured data from unstructured sources. Extract any information from Documents, PDF, web or Audios to a flat file with AI, ensure quality even for long documents.

Seed $3.8M
The Blue Box Biomedical Solutions

Women aged 20-45 cannot get screened for breast cancer because existing solutions are unreliable. However, 81% want to. At The Blue Box, we have built a pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine with a sensitivity of 83%. In 2024, we’ll launch into the market, bringing The Blue Box to private gynecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.

Seed $3.5M
Aily Labs

Aily Labs is involved in the creation of digital artificial intelligence products.

Venture - Series Unknown $80.0M
Vidext

We transform text into recordings in excess of 40 dialects. Increment your effect, reach and commitment. Decline your work, spending plan and cerebral pains.

Series A $7.0M
Remuner

The software developed by Remuner automates the calculation of variable pay, particularly sales commissions. It effectively incorporates both company and employee goals and rewards. By utilizing artificial intelligence and analytics, the platform enhances overall performance in managing commissions.

Seed $6.5M
Biorce

Biorce is a startup in the medical technology field that creates a clinical AI assistant to improve the efficiency and cost-effectiveness of clinical trials. The company's AI platform simplifies the process of developing protocols, selecting sites, and assessing feasibility, which ultimately speeds up timelines and enhances operational efficiency. With a database of detailed and annotated clinical studies, Biorce helps pharmaceutical companies, biotech companies, and CROs make informed decisions based on data, while still maintaining high standards for quality and patient safety.

Seed $5.9M
Ubyko

Ubyko specializes in using robotics and automation to improve the efficiency of last-mile logistics for urban retail settings.

Seed $510k
Orga AI

Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain.

Series Unknown $450k
Luzia

Luzia created an AI technology that is able to convert spoken messages on WhatsApp into written text. Their platform features a chatbot that can respond to inquiries on different subjects, create text, translate languages, and even produce creative content, enabling users to engage in a wide range of tasks.

Series Unknown $13.5M
Harmonix

Harmonix is a software development firm utilizing AI in customer relationship management to send communications to clients via email, phone calls, and SMS messages.

Seed $3.5M
Irisbond
Series Unknown $4.9M
unusuals

Unusuals specializes in leveraging artificial intelligence to automate infrastructure maintenance and inspection processes. By harnessing cross-sector data along with customer expertise, Unusuals aims to make AI accessible for infrastructure owners, simplifying, visualizing, and automating tasks such as powerline inspections. Their platform, which can be deployed both cloud-based or on-premises, focuses on unlocking the potential of visual data to enhance control over infrastructures, thereby facilitating savings and efficiency improvements. With a team of diverse experts, Unusuals is dedicated to transforming the way infrastructures are managed through innovative AI solutions.

Series Unknown
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.